
FGH-10019
CAS No. 1046045-61-7
FGH-10019 ( —— )
产品货号. M21072 CAS No. 1046045-61-7
FGH-10019 是一种新型甾醇调节元件结合蛋白 (SREBP) 抑制剂 (IC50:1 μM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2195 | 有现货 |
![]() ![]() |
10MG | ¥3183 | 有现货 |
![]() ![]() |
25MG | ¥5330 | 有现货 |
![]() ![]() |
50MG | ¥7590 | 有现货 |
![]() ![]() |
100MG | ¥10287 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称FGH-10019
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述FGH-10019 是一种新型甾醇调节元件结合蛋白 (SREBP) 抑制剂 (IC50:1 μM)。
-
产品描述FGH-10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).
-
体外实验Treatment of the CHO-K1 cells with analog FGH10019 decreases the percentage of the mature form of SREBP-2 (68 kDa) at lower concentrations than treatment with fatostatin. Densitometric analysis of the gels indicates that the IC50 of analog FGH10019 is approximately 1 μM, which is 5-10 times lower than the IC50 of fatostatin (appr 10 μM).
-
体内实验FGH10019-treated chow is fed at a dose rate calculated to provide about 0.7 mg analog FGH10019 per day, at about 23 mg/kg body weight, to 5-wk-old male ob/ob mice weighing an average of appr 30 g. After 8 wk on the analog 24-treated chow, the mice gain 8-9 % less weight than control mice.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体SREBPs
-
研究领域——
-
适应症——
化学信息
-
CAS Number1046045-61-7
-
分子量373.49
-
分子式C18H19N3O2S2
-
纯度>98% (HPLC)
-
溶解度DMSO:38 mg/mL (101.74 mM)
-
SMILESCCCc1cc(-c2nc(-c3ccc(NS(C)(=O)=O)cc3)cs2)ccn1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kamisuki S Shirakawa T Kugimiya A et al. Synthesis and Evaluation of Diarylthiazole Derivatives That Inhibit Activation of Sterol Regulatory Element-Binding Proteins[J]. Journal of Medicinal Chemistry 2011 54(13):4923-4927.
产品手册




关联产品
-
Cephaeline hydrochlo...
Cephaeline hydrochloride
-
Oxyphyllol B
The rhizoma of Bupleurum longibrachiatum Turcz.
-
Protoporphyrin IX
原卟啉 IX 在卟啉代谢中由原卟啉原氧化酶产生。